Stockreport

BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update

BioNTech SE - American Depositary Shares  (BNTX) 
PDF   Advanced oncology pipeline in mid- and late-stage with plans to have ten or more potentially registrational oncology trials running by the end of 2024Aiming for fi [Read more]